AN2 Therapeutics, Inc. (ANTX)

4.00 +0.20 (+5.26%) USD  |  NASDAQ  |  Apr 22, 16:00
4.00 0.00 (0.00%) After-Hours: 18:30
More

AN2 Therapeutics Consensus Recommendation

Consensus Recommendation Chart

View Consensus Recommendation for ANTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Consensus Recommendation Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Consensus Recommendation Range, Past 5 Years

View Consensus Recommendation Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Consensus Recommendation Benchmarks

View Consensus Recommendation Benchmarks
Start Trial
Relmada Therapeutics, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
Savara, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade